Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.

Rennes University Hospital

Status

Completed

Conditions

Type 1 Diabetes

Treatments

Other: Continuous glucose monitoring

Other: Insulin Pump

Other: A decision support software

Study type

Interventional

Funder types

Other

Identifiers

NCT01883024

2013-A00495-40

LOC 1308 (Other Identifier)

Details and patient eligibility

About

The purpose of the study is to assess the relevance of the advices provided by the IPRA© smartphone application for guiding the responses of insulin pump treated type 1 diabetes patients using real-time continuous glucose monitoring.

Full description

Patients will be asked to evaluate the IPRA advices by connecting to IPRA© application by using their smartphone, 30 times a week for two weeks. At the end of this two week period, a satisfaction questionnaire will be completed.

Enrollment

6 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

men and women ≥ 18 years of age,
patients with type 1 diabetes for more than 2 years,
patients treated by insulin pump for more than 6 months,
patients using of real-time continuous glucose monitoring for more than 3 months,
patients able to evaluate the IPRA advices by connecting to IPRA© application 30 times a week,
patient able to provide written informed consent,
patient able to provide written non-disclosure agreement

Exclusion criteria

pregnancy or breastfeeding,
current infectious disease,
patients with no smartphone® or Internet access,
adults legally protected (under judicial protection, guardianship, or supervision), persons deprived of their liberty